Pathstone Family Office’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,000
Closed -$5K 914
2021
Q3
$5K Buy
+2,000
New +$168K ﹤0.01% 863

Other funds holding CVS

Pathstone Family Office's CVS Position: Q3 2023 in Review

Pathstone Family Office increased its CVS Health (CVS) stake by 23% in Q3 2023, buying an estimated $1.88M and bringing the position to 141,150 shares worth $9.87M. The position accounts for 0.08% of the portfolio, ranked #174.

Pathstone Family Office first reported a position in CVS in Q2 2013 and has held it in 34 quarters since. The position peaked at $23.9M in Q3 2022. 2,114 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • Pathstone Family Office held 141,150 shares of CVS Health worth $9.87M as of Q3 2023.
  • Pathstone Family Office bought 26,602 CVS Health shares in Q3 2023, an estimated $1.88M.
  • CVS Health made up 0.08% of Pathstone Family Office's portfolio in Q3 2023, its #174 holding.
  • Pathstone Family Office first reported a position in CVS Health in Q2 2013 and has held it in 34 quarters since.
  • Pathstone Family Office's CVS Health position peaked at $23.9M in Q3 2022.
  • 2,114 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.